Thursday July 18, 2019 02:02

Heathcare Press Release : 25 Nov 2016

Treatment Brings New Hope for Patients Suffering From Fatal Lung Disease From Fatal Lung Disease Heathcare—25 Nov 16

Idopathic Pulmonary Fibrosis (IPF) is a debilitating and fatal lung disease that currently affects approximately 3 million people worldwide with a median survival of 2-3 years after diagnosis (1)(2). It is a silent killer that many are not aware of.